# Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections

> **NCT06352554** · — · UNKNOWN · sponsor: **SpeeDx Pty Ltd** · enrollment: 100 (estimated)

## Conditions studied

- Diagnosis
- Gonorrhea
- Resistance Bacterial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06352554
- **Lead sponsor:** SpeeDx Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-08
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-01-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06352554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06352554, "Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06352554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*